What is Gitelman syndrome

TL;DR: Gitelman syndrome is a rare genetic kidney disorder that impairs the body’s ability to reabsorb salt, leading to an imbalance of electrolytes like potassium and magnesium in the blood. Patients with Gitelman syndrome often experience muscle weakness, fatigue, and cramping, and the condition typically requires lifelong management to replace these essential minerals.

What exactly is Gitelman syndrome?

Gitelman syndrome is a salt-wasting tubulopathy, meaning it specifically affects the distal convoluted tubule of the kidney. In a healthy person, these tubules act as a filter that reclaims salt and minerals from the urine to return them to the bloodstream. In individuals with Gitelman syndrome, this reabsorption process is defective. As a result, the body loses excessive amounts of sodium, chloride, potassium, and magnesium through the urine, which disrupts the delicate chemical balance required for muscles and nerves to function correctly.

How common is Gitelman syndrome and who does it affect?

Gitelman syndrome is considered a rare condition, with an estimated prevalence of approximately 1 in 40,000 people in the general population. While the disorder is genetic, symptoms often do not appear until late childhood, adolescence, or even early adulthood. Unlike some other kidney disorders that present in infancy, Gitelman syndrome is rarely diagnosed in very young children. Both males and females are affected equally, and the condition is found globally across all ethnic groups.

What causes Gitelman syndrome?

The underlying mechanism of Gitelman syndrome involves mutations in the SLC12A3 gene. This gene provides instructions for creating the thiazide-sensitive sodium-chloride cotransporter (NCC) protein, which sits on the surface of kidney cells and acts as a "gatekeeper" for salt reabsorption. When this protein is faulty, the kidney cannot effectively pull salt back into the body. Gitelman syndrome is inherited in an autosomal recessive pattern, meaning a person must inherit one mutated copy of the gene from each parent to manifest the condition.

How does Gitelman syndrome differ from other kidney disorders?

It is common to confuse Gitelman syndrome with Bartter syndrome, but there are distinct clinical differences. Clinicians look for specific markers to differentiate them:

• Electrolyte profile: Gitelman syndrome is uniquely characterized by hypomagnesemia (low blood magnesium) and hypocalciuria (low calcium in the urine).


• Age of onset: Bartter syndrome typically presents in infancy with more severe symptoms, whereas Gitelman syndrome is generally milder and presents later in life.


• Blood pressure: Patients with Gitelman syndrome often have low-to-normal blood pressure, which helps clinicians distinguish it from other forms of salt-wasting.

Currently, 111 people with Gitelman syndrome have joined the DiseaseMaps.org community, sharing their lived experiences and coping strategies for managing daily electrolyte replacement therapies.

Next steps

• Consult with a nephrologist who specializes in tubular disorders to establish a baseline for your electrolyte levels.


• Keep a daily log of symptoms, such as muscle cramps or fatigue, to share with your medical team.


• Connect with the DiseaseMaps community to learn how others manage the dietary and supplemental requirements of Gitelman syndrome.


• Discuss with a genetic counselor the implications of an SLC12A3 mutation for family planning.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• National Institutes of Health (NIH) Genetic and Rare Diseases Information Center (GARD): Gitelman Syndrome.


• Orphanet: Gitelman Syndrome (ORPHA:371).


• Online Mendelian Inheritance in Man (OMIM): #263800 Gitelman Syndrome.


• The Gitelman Syndrome Foundation: Patient Education and Resources.